NO20083240L - Sammensetninger og fremgangsmater for forebygging og behandling av kakeksia - Google Patents
Sammensetninger og fremgangsmater for forebygging og behandling av kakeksiaInfo
- Publication number
- NO20083240L NO20083240L NO20083240A NO20083240A NO20083240L NO 20083240 L NO20083240 L NO 20083240L NO 20083240 A NO20083240 A NO 20083240A NO 20083240 A NO20083240 A NO 20083240A NO 20083240 L NO20083240 L NO 20083240L
- Authority
- NO
- Norway
- Prior art keywords
- compositions
- methods
- treatment
- swine
- cachexia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75311805P | 2005-12-22 | 2005-12-22 | |
US77275206P | 2006-02-13 | 2006-02-13 | |
PCT/IB2006/004315 WO2008093148A2 (fr) | 2005-12-22 | 2006-12-20 | Compositions et procédés pour la prévention et le traitement de la cachexie |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083240L true NO20083240L (no) | 2008-09-22 |
Family
ID=38194678
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083240A NO20083240L (no) | 2005-12-22 | 2008-07-22 | Sammensetninger og fremgangsmater for forebygging og behandling av kakeksia |
Country Status (6)
Country | Link |
---|---|
US (1) | US8080528B2 (fr) |
EP (1) | EP1991270A4 (fr) |
JP (1) | JP2009526087A (fr) |
MX (1) | MX2008007790A (fr) |
NO (1) | NO20083240L (fr) |
WO (1) | WO2008093148A2 (fr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7417038B1 (en) | 1998-10-15 | 2008-08-26 | Imperial Innovations Limited | Methods of treating cachexia |
GB0624282D0 (en) | 2006-12-05 | 2007-01-10 | Cavalla David | Treatment of cachexia |
AU2008240379B2 (en) * | 2007-04-24 | 2012-10-04 | Acacia Pharma Limited | Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss |
WO2008144763A2 (fr) | 2007-05-21 | 2008-11-27 | Alder Biopharmaceuticals, Inc. | Anticorps anti-il-6 et leur utilisation |
US8252286B2 (en) | 2007-05-21 | 2012-08-28 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
US9701747B2 (en) | 2007-05-21 | 2017-07-11 | Alderbio Holdings Llc | Method of improving patient survivability and quality of life by anti-IL-6 antibody administration |
US8178101B2 (en) | 2007-05-21 | 2012-05-15 | Alderbio Holdings Inc. | Use of anti-IL-6 antibodies having specific binding properties to treat cachexia |
US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
US7906117B2 (en) | 2007-05-21 | 2011-03-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
US8404235B2 (en) | 2007-05-21 | 2013-03-26 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
US20090221518A1 (en) * | 2007-11-18 | 2009-09-03 | Anaborex, Inc. | Compositions and Methods for Treatment of Exudative Serous Effusion |
WO2009120836A1 (fr) * | 2008-03-26 | 2009-10-01 | Neurosigma, Inc. | Procédés d’identification et de ciblage de régions du cerveau autonome |
US8323649B2 (en) | 2008-11-25 | 2012-12-04 | Alderbio Holdings Llc | Antibodies to IL-6 and use thereof |
US8992920B2 (en) | 2008-11-25 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of arthritis |
US9212223B2 (en) | 2008-11-25 | 2015-12-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
US8337847B2 (en) | 2008-11-25 | 2012-12-25 | Alderbio Holdings Llc | Methods of treating anemia using anti-IL-6 antibodies |
US9452227B2 (en) | 2008-11-25 | 2016-09-27 | Alderbio Holdings Llc | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
US8420089B2 (en) | 2008-11-25 | 2013-04-16 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
SG171804A1 (en) * | 2008-11-25 | 2011-07-28 | Alder Biopharmaceuticals Inc | Antibodies to il-6 and use thereof |
WO2011066369A2 (fr) | 2009-11-24 | 2011-06-03 | Alder Biopharmaceuticals, Inc. | Antagonistes de l'il-6 destinés à faire augmenter l'albumine et/ou à faire baisser la crp |
US9775921B2 (en) | 2009-11-24 | 2017-10-03 | Alderbio Holdings Llc | Subcutaneously administrable composition containing anti-IL-6 antibody |
WO2012009542A2 (fr) * | 2010-07-14 | 2012-01-19 | Kansas State University Research Foundation | Procédés de soulagement de la douleur chronique et d'amélioration de la performance du bétail subissant un écornage ou une castration |
ES2847891T3 (es) | 2010-11-23 | 2021-08-04 | Vitaeris Inc | Anticuerpos anti-IL-6 para el tratamiento de la mucositis oral |
KR20210075191A (ko) * | 2012-03-28 | 2021-06-22 | 애피바디 에이비 | 경구투여 |
WO2020018554A1 (fr) * | 2018-07-17 | 2020-01-23 | The Regents Of The University Of California | Méthodes de traitement d'une maladie rénale |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4859782A (en) * | 1986-06-26 | 1989-08-22 | Harbor Branch Oceanographic Institution, Inc. | Misakinolide compositions and their derivatives |
ATE149089T1 (de) | 1987-09-15 | 1997-03-15 | Rowett Research Inst | Anwendungsgebiete von beta-adrenergenen agonisten |
HUT50044A (en) * | 1988-04-12 | 1989-12-28 | Bristol Myers Co | Process for producing pharmaceutical composition comprising megestrol acetate as active ingredient |
US5252564A (en) * | 1991-03-29 | 1993-10-12 | The United States Of America As Represented By The Secretary Of Agriculture | Method to decrease cortisol secretion by feeding melengesterol acetate |
EP0771205A2 (fr) * | 1994-06-28 | 1997-05-07 | Dr. Zerle Gmbh | Nouvelles utilisations cliniques de polyenes-macrolides |
US5750493A (en) * | 1995-08-30 | 1998-05-12 | Raymond F. Schinazi | Method to improve the biological and antiviral activity of protease inhibitors |
US6706892B1 (en) * | 1999-09-07 | 2004-03-16 | Conjuchem, Inc. | Pulmonary delivery for bioconjugation |
US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
US7211568B2 (en) * | 2003-12-18 | 2007-05-01 | Kosan Biosciences Incorporated | 9-Desoxoerythromycin compounds as prokinetic agents |
WO2008004224A2 (fr) | 2006-07-03 | 2008-01-10 | Arie Levine | Compositions synergiques pour la maladie de crohn et des troubles gastro-intestinaux inflammatoires |
-
2006
- 2006-12-20 MX MX2008007790A patent/MX2008007790A/es not_active Application Discontinuation
- 2006-12-20 WO PCT/IB2006/004315 patent/WO2008093148A2/fr active Application Filing
- 2006-12-20 EP EP06852000A patent/EP1991270A4/fr not_active Withdrawn
- 2006-12-20 JP JP2008555886A patent/JP2009526087A/ja not_active Withdrawn
- 2006-12-20 US US11/614,056 patent/US8080528B2/en not_active Expired - Fee Related
-
2008
- 2008-07-22 NO NO20083240A patent/NO20083240L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1991270A2 (fr) | 2008-11-19 |
JP2009526087A (ja) | 2009-07-16 |
WO2008093148A2 (fr) | 2008-08-07 |
US20070149465A1 (en) | 2007-06-28 |
US8080528B2 (en) | 2011-12-20 |
EP1991270A4 (fr) | 2009-12-02 |
WO2008093148A3 (fr) | 2009-04-16 |
MX2008007790A (es) | 2009-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083240L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av kakeksia | |
WO2007095497A3 (fr) | Compositions et méthodes pour prévenir et traiter la cachexie | |
NO20062300L (no) | Fremgangsmater og reagenser for behandling av inflammatoriske forstyrelser | |
BRPI0508254A (pt) | métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos | |
DE602006013191D1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
ECSP17000643A (es) | Combinación farmacéutica que comprende 3-(3-dimetilamino-1etil-2-metil-propil)-fenol y Paracetamol. | |
TW200631578A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of central nervous system injury | |
ATE510538T1 (de) | Zusammensetzungen und verfahren für nervenschutz | |
EA200970542A1 (ru) | ИНГИБИТОРЫ ДЕЙСТВИЯ Akt | |
ES2571730T3 (es) | Composiciones farmacéuticas que comprenden droxidopa | |
BRPI0413326A (pt) | métodos para tratar doença cardiovasculares empregando-se uma molécula ctla4 solúvel | |
MX2007006066A (es) | Inhibidores de jnk para el tratamiento de lesiones del snc. | |
GT200600160A (es) | Tratamiento del dolor | |
CL2008001782A1 (es) | Uso de una composicion que comprende un compuesto derivado de heterociclo para tratar o prevenir la perdida de flujo intestinal; composicion que comprende dicho compusto; y kit que comprende la composicion. | |
CL2008000202A1 (es) | Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor. | |
MX2008015775A (es) | Compuestos y composiciones para tratamiento de cancer. | |
ATE522500T1 (de) | Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür | |
NO20073104L (no) | Anvendelse av en 5-HT6 agonist for behandling og forebygging av neurodegenerative forstyrrelser | |
EA200901062A1 (ru) | Использование ингибиторов растворимой эпоксидгидролазы для предотвращения и лечения метаболического синдрома и соответствующих расстройств | |
EA200970338A2 (ru) | Агонисты рецептора еро человека, композиции, способы и применение для предотвращения или лечения состояний, связанных с интолерантностью к глюкозе | |
NO20092230L (no) | Azabicykliske heterocykler som cannabinoid reseptor modulatorer | |
EA202190678A1 (ru) | Вибегрон для лечения симптомов гиперактивного мочевого пузыря | |
EA201990365A1 (ru) | Лечение и предотвращение расстройств сна | |
EA200800343A1 (ru) | Ингибиторы jnk для лечения эндометриоза | |
UY29237A1 (es) | Metodos detratamiento y prevencion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |